Developer docs
API playgroundTry for free, no card

Search company profiles

Hereditary Disease Foundation

Full company profile

uuid02lpff6

Namestring
Hereditary Disease Foundation
Legal namestring
Huntington's Disease Foundation
Company typeenum
Private
Founded yearint
1968
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Huntington's disease research, Research grant funding, Postdoctoral fellowships, Biomedical research grants, Disease research foundation
Industry2 codes
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAA
Private Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code3 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services8132
Product category
Non-Profit Disease Research Grant Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Charitable Donations
TypeGrants Donations
Description

The foundation generates revenue through individual donations, employer matching gifts, IRA qualified charitable distributions, gifts of stock, donor advised funds, and legacy giving/bequests. HDF is a registered 501(c)(3) non-profit organization with EIN 23-7376197.

hdfoundation.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Others, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Nancy S. Wexler Discovery Fund
Description

A fund established in 2020 to honor Dr. Nancy Wexler's contributions to Huntington's disease research, supporting recruitment of young scientists, collaborative research, educational workshops, conferences, and the Nancy S. Wexler Young Investigator Prize.

hdfoundation.org
+2 more records
Core offering1 text field

The Hereditary Disease Foundation (now operating as Huntington's Disease Foundation) is a 501(c)(3) non-profit foundation that funds innovative scientific research into Huntington's disease and related brain disorders. It awards research grants, postdoctoral fellowships, transformative research awards, and scientific prizes, and convenes the HD research community through biennial symposia, workshops, and webinars. The foundation is sustained entirely by charitable contributions from individual donors, planned gifts, employer matching programs, and partner sponsorships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Discovery of the Huntington's disease genetic marker in 1983, leading to gene identification in 1993
+2 more records
Product overview1 text field

The Huntington's Disease Foundation (formerly Hereditary Disease Foundation) is a non-profit organization focused on funding innovative research to cure Huntington's disease. The Foundation's portfolio consists of grant and fellowship programs including Transformative Research Awards (million-dollar collaborative grants), HD Career Advancement Grants (postdoc-to-PI transition support), Postdoctoral Fellowships ($100,000/year for 2 years), and Research Grants ($100,000 for 1 year). The Foundation also operates an awards program with the Leslie Gehry Prize for Innovation in Science and the Nancy S. Wexler Young Investigator Prize. Scientific community engagement includes the Milton Wexler Biennial Symposium, HDF Workshops, Research Spotlight Webinars, and a Young Investigators Program. The Foundation supports donations through multiple channels including DAF, IRA QCD, stock gifts, and legacy giving.

Product and service9 records
1HDF Prizes Program
CategoryAward and Recognition Program
Description

Annual awards recognizing extraordinary scientific contributions to Huntington's disease research, encompassing the Leslie Gehry Prize for Innovation in Science and the Nancy S. Wexler Young Investigator Prize. Aimed at scientists and researchers working on HD.

2Huntington's Disease Career Advancement Grants (HD-CAG)
CategoryResearch Grant Program
Description

Incubator grant program supporting young investigators transitioning from postdoctoral positions to tenure-track primary investigator roles by providing resources, tools, and skill-building opportunities in Huntington's disease research.

3Transformative Research Awards
CategoryResearch Grant Program
Description

Approximately $1 million collaborative research awards funding interdisciplinary research teams to develop innovative approaches for studying new pathogenic disease mechanisms and treatment modalities in Huntington's disease.

4HDF Postdoctoral Fellowships
CategoryFellowship Program
Description

Two-year fellowships of $100,000 per year funding early-career scientists to cultivate interest and expertise in Huntington's disease research. Open to early-career postdoctoral researchers worldwide.

5HDF Research Grants
CategoryResearch Grant Program
Description

One-year seed grants of $100,000 providing experienced researchers with preliminary funding to collect data needed to obtain major long-term funding from other organizations such as the NIH.

6Research Spotlight Webinars
CategoryEducational Program
Description

Online webinar series featuring HD scientists presenting research in accessible, non-technical language for general audiences, with recordings archived on YouTube. Sponsored by pharmaceutical/biotech industry partners.

7Milton Wexler Biennial Symposium
CategoryScientific Conference
Description

Biennial scientific conference convening over 300 of the world's foremost experts in Huntington's disease and other neurological diseases to share discoveries and explore cutting-edge research approaches.

8HDF Workshops
CategoryScientific Conference
Description

Small interdisciplinary scientific workshops bringing together early-career and senior researchers from academia and industry to encourage brainstorming and exploration of new HD research directions.

9HDF Donations Platform
CategoryCharitable Donation Service
Description

Online donation platform supporting Huntington's disease research, offering one-time and recurring donations, donor-advised fund (DAF) gifts, IRA qualified charitable distributions (QCDs), gifts of stock, and legacy/bequest giving.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
1Bristol Myers Squibb (BMS)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting the Huntington's Disease Foundation's Research Spotlight Webinars program.

hdfoundation.org
Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor and strategic partner. C. Frank Bennett, Chief Scientific Officer of Ionis, serves on HDF's Scientific Advisory Board and received the 2018 Leslie Gehry Prize.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting the Huntington's Disease Foundation's research education initiatives.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting HD research webinars and education.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting HD research education initiatives.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting Huntington's disease research communication.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting HD research webinars.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Webinar sponsor supporting HD research education.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

HDBuzz is co-founded by Jeff Carroll (2025 Leslie Gehry Prize recipient) and provides plain-language HD research news. HDF promotes HDBuzz as a trusted resource for HD families.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership to provide free online legacy giving tool for donors to include HDF in their wills at no cost.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Provides matching gift and volunteer grant information for employer gift matching programs.

12ProposalCentral
Strategic tierCoreTypeTechnology or Integration
Description

Grant management platform used for submitting Letters of Intent and funding applications for HDF grants and fellowships.

hdfoundation.org
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hereditary Disease Foundation

Non-Profit Disease Research Grant Fundinghdfoundation.org

Hereditary Disease Foundation firmographics

Firmographics
Name
Hereditary Disease Foundation
Legal name
Huntington's Disease Foundation
Website
https://hdfoundation.org
Company type
Private
Founded year
1968
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Hereditary Disease Foundation is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hereditary Disease Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Marketing or Sales, Operations

Revenue model

  1. Charitable Donations: The foundation generates revenue through individual donations, employer matching gifts, IRA qualified charitable distributions, gifts of stock, donor advised funds, and legacy giving/bequests. HDF is a registered 501(c)(3) non-profit organization with EIN 23-7376197.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Hereditary Disease Foundation product offering

Product offering

Core offering

The Hereditary Disease Foundation (now operating as Huntington's Disease Foundation) is a 501(c)(3) non-profit foundation that funds innovative scientific research into Huntington's disease and related brain disorders. It awards research grants, postdoctoral fellowships, transformative research awards, and scientific prizes, and convenes the HD research community through biennial symposia, workshops, and webinars. The foundation is sustained entirely by charitable contributions from individual donors, planned gifts, employer matching programs, and partner sponsorships.

Product overview

The Huntington's Disease Foundation (formerly Hereditary Disease Foundation) is a non-profit organization focused on funding innovative research to cure Huntington's disease. The Foundation's portfolio consists of grant and fellowship programs including Transformative Research Awards (million-dollar collaborative grants), HD Career Advancement Grants (postdoc-to-PI transition support), Postdoctoral Fellowships ($100,000/year for 2 years), and Research Grants ($100,000 for 1 year). The Foundation also operates an awards program with the Leslie Gehry Prize for Innovation in Science and the Nancy S. Wexler Young Investigator Prize. Scientific community engagement includes the Milton Wexler Biennial Symposium, HDF Workshops, Research Spotlight Webinars, and a Young Investigators Program. The Foundation supports donations through multiple channels including DAF, IRA QCD, stock gifts, and legacy giving.

Differentiator

Problem solved

Functional benefit

Brands

  • Nancy S. Wexler Discovery Fund: A fund established in 2020 to honor Dr. Nancy Wexler's contributions to Huntington's disease research, supporting recruitment of young scientists, collaborative research, educational workshops, conferences, and the Nancy S. Wexler Young Investigator Prize.
  • Leslie Gehry Prize for Innovation in Science
  • Nancy S. Wexler Young Investigator Prize

Products and services

  • HDF Prizes Program Annual awards recognizing extraordinary scientific contributions to Huntington's disease research, encompassing the Leslie Gehry Prize for Innovation in Science and the Nancy S. Wexler Young Investigator Prize. Aimed at scientists and researchers working on HD.
  • Huntington's Disease Career Advancement Grants (HD-CAG) Incubator grant program supporting young investigators transitioning from postdoctoral positions to tenure-track primary investigator roles by providing resources, tools, and skill-building opportunities in Huntington's disease research.
  • Transformative Research Awards Approximately $1 million collaborative research awards funding interdisciplinary research teams to develop innovative approaches for studying new pathogenic disease mechanisms and treatment modalities in Huntington's disease.
  • HDF Postdoctoral Fellowships Two-year fellowships of $100,000 per year funding early-career scientists to cultivate interest and expertise in Huntington's disease research. Open to early-career postdoctoral researchers worldwide.
  • HDF Research Grants One-year seed grants of $100,000 providing experienced researchers with preliminary funding to collect data needed to obtain major long-term funding from other organizations such as the NIH.
  • Research Spotlight Webinars Online webinar series featuring HD scientists presenting research in accessible, non-technical language for general audiences, with recordings archived on YouTube. Sponsored by pharmaceutical/biotech industry partners.
  • Milton Wexler Biennial Symposium Biennial scientific conference convening over 300 of the world's foremost experts in Huntington's disease and other neurological diseases to share discoveries and explore cutting-edge research approaches.
  • HDF Workshops Small interdisciplinary scientific workshops bringing together early-career and senior researchers from academia and industry to encourage brainstorming and exploration of new HD research directions.
  • HDF Donations Platform Online donation platform supporting Huntington's disease research, offering one-time and recurring donations, donor-advised fund (DAF) gifts, IRA qualified charitable distributions (QCDs), gifts of stock, and legacy/bequest giving.

Quantifiable outcome

  • Discovery of the Huntington's disease genetic marker in 1983, leading to gene identification in 1993
  • +2 more outcomes

Companies that use Hereditary Disease Foundation

Customer profile

Segments5 records

Ideal customer profiles4 records

Hereditary Disease Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hereditary Disease Foundation partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor and core.

  • Bristol Myers Squibb (BMS)minorGTM or Marketing PartnerWebinar sponsor supporting the Huntington's Disease Foundation's Research Spotlight Webinars program.
  • Ionis PharmaceuticalsminorGTM or Marketing PartnerWebinar sponsor and strategic partner. C. Frank Bennett, Chief Scientific Officer of Ionis, serves on HDF's Scientific Advisory Board and received the 2018 Leslie Gehry Prize.
  • NovartisminorGTM or Marketing PartnerWebinar sponsor supporting the Huntington's Disease Foundation's research education initiatives.
  • uniQureminorGTM or Marketing PartnerWebinar sponsor supporting HD research webinars and education.
  • Cleveland ClinicminorGTM or Marketing PartnerWebinar sponsor supporting HD research education initiatives.
  • Neurocrine BiosciencesminorGTM or Marketing PartnerWebinar sponsor supporting Huntington's disease research communication.
  • Rgenta TherapeuticsminorGTM or Marketing PartnerWebinar sponsor supporting HD research webinars.
  • Wave Life SciencesminorGTM or Marketing PartnerWebinar sponsor supporting HD research education.
  • HDBuzzcoreStrategic or Co-development PartnerHDBuzz is co-founded by Jeff Carroll (2025 Leslie Gehry Prize recipient) and provides plain-language HD research news. HDF promotes HDBuzz as a trusted resource for HD families.
  • FreeWillminorGTM or Marketing PartnerPartnership to provide free online legacy giving tool for donors to include HDF in their wills at no cost.
  • Double the DonationminorGTM or Marketing PartnerProvides matching gift and volunteer grant information for employer gift matching programs.
  • ProposalCentralcoreTechnology or IntegrationGrant management platform used for submitting Letters of Intent and funding applications for HDF grants and fellowships.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Hereditary Disease Foundation competitors and assessment

Company assessment

Market position

Weaknesses4 records

Customer concentration

Hereditary Disease Foundation social profiles

Digital presence

Hereditary Disease Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hereditary Disease Foundation leadership team

Management profile

Number of profiles

Profiles3 records

Hereditary Disease Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hereditary Disease Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hereditary Disease Foundation

What does Hereditary Disease Foundation do?

The Hereditary Disease Foundation (now operating as Huntington's Disease Foundation) is a 501(c)(3) non-profit foundation that funds innovative scientific research into Huntington's disease and related brain disorders. It awards research grants, postdoctoral fellowships, transformative research awards, and scientific prizes, and convenes the HD research community through biennial symposia, workshops, and webinars. The foundation is sustained entirely by charitable contributions from individual donors, planned gifts, employer matching programs, and partner sponsorships.

Is Hereditary Disease Foundation a public or private company?

Hereditary Disease Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Hereditary Disease Foundation founded?

Hereditary Disease Foundation was founded in 1968. It employs 11 to 50 people.

Where is Hereditary Disease Foundation based?

Hereditary Disease Foundation is headquartered in New York, United States, in the North America region.

How does Hereditary Disease Foundation make money?

One revenue line is on record: charitable Donations.

Does Hereditary Disease Foundation have an API?

No public API is recorded for Hereditary Disease Foundation.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireHereditary Disease Foundation Announces Recipients of Inaugural Transformative Research AwardThe Hereditary Disease Foundation announced its first Transformative Research Awards, giving $1 million each to teams led by Beverly Davidson and Ricardo Mouro Pinto. The funds will support two-year projects developing treatments for Huntington's disease, including viral delivery and CRISPR base editing approaches.GlobeNewswireHereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease ResearchThe Hereditary Disease Foundation announced its 2022 prize winners for Huntington's disease research: Steven Finkbeiner won the Leslie Gehry Prize for Innovation in Science, and Natalia Barbosa won the Nancy S. Wexler Young Investigator Prize. Both will speak at the foundation's virtual gala on November 10.GlobeNewswireHereditary Disease Foundation Announces 2021 Prizes Recognizing Leadership in Huntington’s Disease ResearchThe Hereditary Disease Foundation announced its 2021 awards, giving the Leslie Gehry Brenner Prize to Elena Cattaneo and the Nancy S. Wexler Young Investigator Prize to Sarah Hernandez. The awards will be presented at a virtual gala on November 18. The prizes recognize research on Huntington's disease treatments and cures.PR NewswireHereditary Disease Foundation Launches Fund in Honor of Biomedical Pioneer and Huntington's Disease Researcher Nancy S. WexlerThe Hereditary Disease Foundation announced the establishment of the Nancy S. Wexler Discovery Fund, a research initiative honoring Dr. Nancy S. Wexler, who led the 1993 discovery of the Huntington's disease gene and recently revealed her own diagnosis with the disease. The fund launches with $350,000 in gifts and pledges, and will annually award the Nancy S. Wexler Young Investigator Prize to support young scientists and advance Huntington's disease research collaborations. Dr. Osama Al-Dalahmah of Columbia University received the inaugural prize for his work on astrocytes and neuroprotection in Huntington's disease.PR NewswireDr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in ScienceDr. C. Frank Bennett, senior vice president of research at Ionis Pharmaceuticals, received the Hereditary Disease Foundation's 2018 Leslie Gehry Brenner Prize for Innovation in Science for his leadership in developing antisense therapies for Huntington's disease. IONIS-HTT Rx, the drug he helped develop, is the first and only treatment to demonstrate reduction of the neurotoxic mutant huntingtin protein in patients. Dr. Bennett was also announced as a recipient of the 2019 Breakthrough Prize in Life Sciences for his work on SPINRAZA® (nusinersen), the first approved treatment for spinal muscular atrophy.PR NewswireInternational Scientists and Industry Leaders Explore Latest Developments in Brain Research at Hereditary Disease Foundation SymposiumWorld-renowned scientists and industry leaders gathered at the Hereditary Disease Foundation's 10th biennial symposium in Cambridge, MA in early August 2016 to present the latest research on Huntington's disease and other devastating brain disorders. A key development discussed at the event was the Phase 1 clinical trial of IONIS-HTT Rx by Ionis Pharmaceuticals, which targets the genetic cause of Huntington's disease by reducing production of the huntingtin protein. The Foundation noted that progress in Huntington's disease research could serve as a model for treating other brain disorders with more complex genetics, including Parkinson's, Alzheimer's, and ALS.